Neuroradiolological Analysis of COVID-19 Patients

Imaging Analysis of COVID-19 + Patients With Abnormal Neurological Examination

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04368390

Acronym

NEURO-COVID-19

Enrollment

100

Registered

2020-04-29

Start date

2020-04-03

Completion date

2021-04-30

Last updated

2020-12-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid-19

Keywords

COVID-19, MRI, Brain

Brief summary

To describe the radiological presentation of brain abnormalities in COVID-19 + patients

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* Adults * COVID-19 + * Abnormal neurological examination * who underwent a brain MRI

Exclusion criteria

* No participation agreement * Non COVID-19 patients * Patients COVID-19 + without neurological abnormality or without MRI examination

Design outcomes

Primary

Measure	Time frame
Neuroradiological analysis of patients brain MRI	1 year

Countries

France

Contacts

Primary ContactStephane Kremer, MD, PhD

stephane.kremer@chru-strasbourg.fr33 3 88 12 78 89

Backup ContactSaïd CHAYER, PhD, HDR

said.chayer@chru-strasbourg.fr33 3 88 11 66 90

Outcome results